20 reports

  • Allergy Drugs Industry Structure
  • Allergy Drugs Sales Volume

Chart ##: China' s Allergy Drugs Sales Volume (Billion Yuan) INTRODUCTION Chapter I Allergy Drugs Industry Structure CHAPTER III ALLERGY DRUGS INDUSTRY ASSESSMENTS Since 2008, allergy drugs consumption has been growi

  • Allergy Drug
  • China
  • Eisai Co., Ltd.
  • Sanofi-Synthelabo Inc.
  • Schering-Plough China Inc.
  • Allergy Drugs Sales Volume
  • Allergy Drugs Markets in China

The allergy drugs industry is one of key sectors of Chinese industry and has become more and more important.

  • Allergy Drug
  • China
  • Demand
  • Eisai Co., Ltd.
  • Schering-Plough China Inc.
  • ALLERGY DRUGS IMPORT (BILLION YUAN)
  • ALLERGY DRUGS EXPORT (BILLION YUAN)

As many allergy drugs' consumed characters are the same with the normal daily used products, and brand effect is one of them.

  • Allergy Drug
  • China
  • Demand
  • Market Size
  • Trade

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Allergy Drug
  • Allergy Immunotherapy
  • Therapy
  • Biomay AG
  • STANDARDIZED MITE (DERMATOPHAGOIDES PTERONYSSINUS + DERMATOPHAGOIDES FARINAE) ALLERGEN EXTRACT - DRUG PROFILE

HOUSE DUST MITE ALLERGY - PIPELINE BY STALLERGENES GREER PLC, H## 2019 House Dust Mite Allergy - Drug Profiles ALLERGAN FOR DUST MITE ALLERGY - DRUG PROFILE ALLERGEN FOR ALLERGIC ASTHMA AND HOUSE DUST MITE ALLERGY - DRUG PROFILE AM-## -

  • Allergy Drug
  • Medical Biotechnology
  • United States
  • World
  • Product Initiative
  • STANDARDIZED MITE (DERMATOPHAGOIDES PTERONYSSINUS + DERMATOPHAGOIDES FARINAE) ALLERGEN EXTRACT - DRUG PROFILE

" House dust mite allergy is one of the most common allergies, impacting the quality of life for patients across ages and geographies.

  • Allergy Drug
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • ALLERGEN FOR ALLERGIC RHINITIS, ALLERGIC RHINO-CONJUNCTIVITIS AND BIRCH POLLEN ALLERGY - DRUG PROFILE
  • ALLERGEN FOR ALLERGIC RHINITIS AND RHINOCONJUNCTIVITIS - DRUG PROFILE

HALMRE-## - DRUG PROFILE POLLINEX QUATTRO GRASS - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Pollinex Quattro Grass Allergy Therapeutics Plc NA GlaxoSmithKline Plc R& D Progress Resea

  • Allergy Drug
  • Eye Disease
  • Ophthalmic Solution
  • Pharmaceutical
  • Product Initiative

Drug Allergy- The allergy from medicines, drugs is the most common form of allergy.

  • Allergy Drug
  • Respiratory Disease
  • World
  • Merck & Co., Inc.
  • Stallergenes Greer plc

EXECUTIVE SUMMARY ##.

  • Allergy Drug
  • OTC
  • APAC
  • Market Shares

Anti-Allergy Drugs ##. ##. ##.

  • Allergy Drug
  • OTC
  • APAC
  • World
  • Market Size
  • ALLERGEN FOR ALLERGIC RHINITIS, ALLERGIC RHINO-CONJUNCTIVITIS AND BIRCH POLLEN ALLERGY - DRUG PROFILE
  • Allergen for Allergic Rhinitis, Allergic Rhino-Conjunctivitis and Birch Pollen Allergy

The drug candidate activates allergen-specific T-helper type ## (Th##) cellular responses with the production of interferons by antigen presenting cells (APC), natural killer cells (NK), and T cells.

  • Allergy Drug
  • Eye Disease
  • Ophthalmic Solution
  • Pharmaceutical
  • Allergy Therapeutics plc

High capital intensity is more than $##. ## of capital to $## of labor; medium is $##. ## to $##. ## of capital to $## of labor; low is less than $##. ## of capital for every $## of labor.

  • Allergy Drug
  • United States
  • Demand
  • Forecast
  • Trade
  • BILASTINE - DRUG PROFILE
  • Chronic Urticaria Or Hives - Product Development Milestones

About ## percent of people who have food allergies are allergic to more than one food.

  • Allergy Drug
  • Therapy
  • Canada
  • United States
  • Product Initiative
  • Sep 28, 2016: Taiho Pharmaceutical Receives Approval to Manufacture and Market Bilanoa Tablets, an Oral Anti-allergy Drug in Japan
  • Chronic Urticaria Or Hives - Product Development Milestones

ABOUT ## PERCENT OF PEOPLE WHO HAVE FOOD ALLERGIES ARE ALLERGIC TO MORE THAN ONE FOOD.

  • Allergy Drug
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Allergy Drug
  • OTC
  • Therapy
  • World
  • Product Initiative

ALLERGIES THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* PROMINENT DRUGS ALLERGIES THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* ALLERGIES THERAPEUTICS CLINICAL TR

  • Allergy Drug
  • Clinical Trial
  • Pharmaceutical
  • Japan
  • World

TYPE I HYPERSENSITIVITY THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* PROMINENT DRUGS TYPE I HYPERSENSITIVITY THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* TYPE I HYPERSENSITIVITY THERAPEUT

  • Allergy
  • Allergy Drug
  • Clinical Trial
  • Pharmaceutical
  • World
  • SMALL MOLECULES FOR SEASONAL ALLERGIC RHINITIS - DRUG PROFILE
  • Research and Development Brief

THE DRUG CANDIDATE IS A MUTANT DERIVATIVE BIRCH POLLEN ALLERGEN BET V ##.

  • Allergy Drug
  • Allergy Immunotherapy
  • Respiratory Disease
  • Therapy
  • Product Initiative
  • Clinical Trial profile. 307 Trial Title
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

DRUG/ MOLECULE REFERS TO PRIMARY INTERVENTION ONLY. ##.

  • Allergy Drug
  • Clinical Trial
  • Molecular Diagnostics
  • Pharmaceutical
  • World
  • 8.3.1 FEATURED NEWS & PRESS RELEASES

Anti-allergy Drug in Japan Bilanoa Tablets, an Oral Anti-allergy Drug in Japan TAIHO HAS FURTHER DEVELOPED THE DRUG AFTER SIGNING A LICENSE AGREEMENT WITH FAES FARMA IN JULY 2012 FOR THE DEVELOPMENT AND MARKETING RIGHTS IN JAPAN.

  • Allergy Drug
  • Dermatological Condition
  • Therapy
  • Company
  • Product Initiative